Severe malformations in infant born to hyperthyroid woman on methimazole

Lancet

Volumn 350, Issue 9090, 1997, Pages 1520-

  Johnsson, Eva ^a   Larsson, Gerd ^a   Ljunggren, Margareta ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; METOPROLOL; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; ARTICLE; CASE REPORT; CONGENITAL MALFORMATION; DRUG SAFETY; ESOPHAGUS ATRESIA; FEMALE; HUMAN; HYPERTHYROIDISM; MALE; NEWBORN; ORAL DRUG ADMINISTRATION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; TRACHEOESOPHAGEAL FISTULA;

EID: 0345367436     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63942-6     Document Type: Article

References (5)

1. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 1994; 170: 90-95.
2. Ramirez A, Espinosa de los Monteros A, Parra A, De Leon B. Eosophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid woman receiving methimazole (Tapazol) during pregnancy. Am J Med Genet 1992; 44: 200-02.
3. Greenburg F. Brief clinical report - Choanal atresia and athelia: methimazole teratogenicity or a new syndrome? Am J Med Genet 1987; 28: 931-34.
4. Briggs GG, Freeman RK, Yaffe SJ, eds. Drugs in pregnancy and lactation, 4th ed. Baltimore: Williams and Wilkins, 1994: 562-64.
5. Vogt T, Stolz W, Landthaler M. Aplasia cutis congenita after exposure to methimazole: a causal relationship? Br J Dermatol 1995; 133: 994-96.